CompletedEUCTR 2020-004653-69
A study of Adjunctive Troriluzole in OCD
This study is completed in the Netherlands, in Italy, and in Spain. It focuses on OCD.
In NetherlandsOCDOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedEUCTR 2021-003834-34
Safety study of efficacy, Safety, and Tolerability of Luvadaxistat in Schizophrenia
This study is completed in Czechia, in Spain, and . It is testing efficacy, Safety, and Tolerability of Luvadaxistat for Schizophrenia.
In Czech RepublicSchizophreniaOther
OngoingEUCTR 2021-005992-38
Safety study of single subcutaneous MIJ821 injection in Depression
This study is ongoing in Spain, in Poland, and . It is testing single subcutaneous MIJ821 injection for Depression.
In SpainDepressionOther
OngoingEUCTR 2022-000574-26
A Phase 2b study with an extension to determine the safety and efficacy of GH001 in people with treatment-resistant depression
This study is ongoing in Ireland, in Czechia, in Poland, .... It focuses on treatment-resistant depression.
In IrelandDepressionOther
CompletedNCT03066505
Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for ADHD
This study is completed in the United States. It is testing Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for ADHD.
In Los AngelesADHDOtherFrom 18 Years to 25 Years
OngoingEUCTR 2014-004937-15
A double-blinded, placebo and lorazepam-controlled, four-way crossover, Phase II study effects of single oral administration of BNC210 on brain activity changes captured...
This study is ongoing in the United Kingdom. It focuses on Anxiety.
In United KingdomAnxietyOther
OngoingEUCTR 2008-001015-38
Central cannabinoid (CB1) receptor antagonist rimonabant for schizophrenia
This study is ongoing in Germany. It is testing central cannabinoid (CB1) receptor antagonist rimonabant for schizophrenia.
In GermanySchizophreniaOther
CompletedNCT01629537
A study of Stellate Ganglion Block in the Treatment of PTSD
This study is completed in the United States. It focuses on PTSD.
In San DiegoPTSDBehavioralOver 18 Years
OngoingEUCTR 2021-004790-31
Safety study of JNJ-55308942 in depression in bipolarity
This study is ongoing in Spain, in Poland, and . It is testing JNJ-55308942 for depression in bipolarity.
In SpainBipolarity, DepressionOther
CompletedNCT04655287
A Register Study of Effects Following Local Variation in Rates of Involuntary Care
This study is completed. It focuses on schizophrenia and currently lists study information in Global.
In GlobalSchizophrenia, BipolarityOtherFrom 18 Years to 65 Years
Enrolling By InvitationNCT07131137
A Remote Life Balance Training Program for People With Schizophrenia
This study is enrolling by invitation. It focuses on schizophrenia and currently lists participation information in Turkey.
In IstanbulSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT01607593
Sertraline for PTSD
This study is completed in Japan. It is testing sertraline for PTSD.
Multiple locations, including KurumePTSDDrugA study involving a medication or substance.Over 18 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.